GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CQ Pharmaceutical Holding Co Ltd (SZSE:000950) » Definitions » Enterprise Value

CQ Pharmaceutical Holding Co (SZSE:000950) Enterprise Value : ¥25,239 Mil (As of May. 22, 2024)


View and export this data going back to 1999. Start your Free Trial

What is CQ Pharmaceutical Holding Co Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CQ Pharmaceutical Holding Co's Enterprise Value is ¥25,239 Mil. CQ Pharmaceutical Holding Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,165 Mil. Therefore, CQ Pharmaceutical Holding Co's EV-to-EBIT ratio for today is 11.66.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, CQ Pharmaceutical Holding Co's Enterprise Value is ¥25,239 Mil. CQ Pharmaceutical Holding Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,165 Mil. Therefore, CQ Pharmaceutical Holding Co's EV-to-EBITDA ratio for today is 11.66.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, CQ Pharmaceutical Holding Co's Enterprise Value is ¥25,239 Mil. CQ Pharmaceutical Holding Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥80,123 Mil. Therefore, CQ Pharmaceutical Holding Co's EV-to-Revenue ratio for today is 0.32.


CQ Pharmaceutical Holding Co Enterprise Value Historical Data

The historical data trend for CQ Pharmaceutical Holding Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CQ Pharmaceutical Holding Co Enterprise Value Chart

CQ Pharmaceutical Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,113.20 21,582.38 23,356.23 25,602.90 23,908.60

CQ Pharmaceutical Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28,586.04 31,330.49 28,607.52 23,908.60 28,146.10

Competitive Comparison of CQ Pharmaceutical Holding Co's Enterprise Value

For the Medical Distribution subindustry, CQ Pharmaceutical Holding Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CQ Pharmaceutical Holding Co's Enterprise Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CQ Pharmaceutical Holding Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where CQ Pharmaceutical Holding Co's Enterprise Value falls into.



CQ Pharmaceutical Holding Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

CQ Pharmaceutical Holding Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

CQ Pharmaceutical Holding Co's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CQ Pharmaceutical Holding Co  (SZSE:000950) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

CQ Pharmaceutical Holding Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=25239.393/2164.612
=11.66

CQ Pharmaceutical Holding Co's current Enterprise Value is ¥25,239 Mil.
CQ Pharmaceutical Holding Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,165 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

CQ Pharmaceutical Holding Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=25239.393/2164.612
=11.66

CQ Pharmaceutical Holding Co's current Enterprise Value is ¥25,239 Mil.
CQ Pharmaceutical Holding Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,165 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

CQ Pharmaceutical Holding Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=25239.393/80123.113
=0.32

CQ Pharmaceutical Holding Co's current Enterprise Value is ¥25,239 Mil.
CQ Pharmaceutical Holding Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥80,123 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CQ Pharmaceutical Holding Co Enterprise Value Related Terms

Thank you for viewing the detailed overview of CQ Pharmaceutical Holding Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


CQ Pharmaceutical Holding Co (SZSE:000950) Business Description

Traded in Other Exchanges
N/A
Address
333 Jinshi Avenue, Yubei District, Chongqing, CHN, 400010
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.

CQ Pharmaceutical Holding Co (SZSE:000950) Headlines

No Headlines